Plerixafor Used in a “Just in Time” Fashion Allows Timely Autologous Hematopoietic Cell Transplant (HCT) in Patients Who Are at High Risk for Inadequate Apheresis
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.454
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV